ロード中...
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
BACKGROUND: Before the advent of neoadjuvant chemotherapy, radiotherapy and surgery alone were associated with a high risk of uncontrolled locoregional relapses in locally advanced breast cancer (LABC). MATERIAL AND METHODS: In the 1990s we initiated two neoadjuvant protocols, where patients with LA...
保存先:
| 出版年: | Acta Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Informa Healthcare
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245178/ https://ncbi.nlm.nih.gov/pubmed/24909504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2014.922215 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|